These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 17552923

  • 1. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
    Jordan KW, Cheng LL.
    Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
    [Abstract] [Full Text] [Related]

  • 2. Metabolic signatures of malignant progression in prostate epithelial cells.
    Teahan O, Bevan CL, Waxman J, Keun HC.
    Int J Biochem Cell Biol; 2011 Jul; 43(7):1002-9. PubMed ID: 20633696
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance spectroscopic studies of the prostate.
    Koutcher JA, Zakian K, Hricak H.
    Mol Urol; 2000 Jul; 4(3):143-52;discussion 153. PubMed ID: 11062368
    [Abstract] [Full Text] [Related]

  • 4. MR imaging and MR spectroscopic imaging of prostate cancer.
    Rajesh A, Coakley FV.
    Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):557-79, vii. PubMed ID: 15271371
    [Abstract] [Full Text] [Related]

  • 5. MRI of the prostate: clinical relevance and emerging applications.
    Mazaheri Y, Shukla-Dave A, Muellner A, Hricak H.
    J Magn Reson Imaging; 2011 Feb; 33(2):258-74. PubMed ID: 21274967
    [Abstract] [Full Text] [Related]

  • 6. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.
    Nayyar R, Kumar R, Kumar V, Jagannathan NR, Gupta NP, Hemal AK.
    BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548
    [Abstract] [Full Text] [Related]

  • 7. [Progress in nuclear magnetic resonance spectroscopy for early cancer diagnosis].
    Gao XX, Xu YZ, Zhao MX, Qi J, Li HZ, Wu JG.
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1942-50. PubMed ID: 18975839
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer.
    Huzjan R, Sala E, Hricak H.
    Nat Clin Pract Urol; 2005 Sep; 2(9):434-42. PubMed ID: 16474681
    [Abstract] [Full Text] [Related]

  • 9. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, Zhao WF, Yang ZH, Zhong CY, Li GZ.
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [Abstract] [Full Text] [Related]

  • 10. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S, Byrum S, Siegel ER, Suva LJ.
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer. Multidisciplinary approach: a key to success.
    Montagut C, Albanell J, Bellmunt J.
    Crit Rev Oncol Hematol; 2008 Oct; 68 Suppl 1():S32-6. PubMed ID: 18723370
    [Abstract] [Full Text] [Related]

  • 12. Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice.
    Rantalainen M, Cloarec O, Beckonert O, Wilson ID, Jackson D, Tonge R, Rowlinson R, Rayner S, Nickson J, Wilkinson RW, Mills JD, Trygg J, Nicholson JK, Holmes E.
    J Proteome Res; 2006 Oct; 5(10):2642-55. PubMed ID: 17022635
    [Abstract] [Full Text] [Related]

  • 13. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging.
    Sciarra A, Salciccia S, Panebianco V.
    Eur Urol; 2008 Sep; 54(3):485-8. PubMed ID: 18439748
    [No Abstract] [Full Text] [Related]

  • 14. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
    Scheidler J, Vogel M, Gross P, Heuck A.
    Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
    [Abstract] [Full Text] [Related]

  • 15. High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer.
    Kumar V, Dwivedi DK, Jagannathan NR.
    NMR Biomed; 2014 Jan; 27(1):80-9. PubMed ID: 23828638
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An introduction to biological nuclear magnetic resonance spectroscopy.
    Bothwell JH, Griffin JL.
    Biol Rev Camb Philos Soc; 2011 May; 86(2):493-510. PubMed ID: 20969720
    [Abstract] [Full Text] [Related]

  • 18. Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging.
    Vilanova JC, Barceló J.
    Abdom Imaging; 2007 May; 32(2):253-61. PubMed ID: 17476554
    [Abstract] [Full Text] [Related]

  • 19. Update of prostate magnetic resonance imaging at 3 T.
    Kim CK, Park BK.
    J Comput Assist Tomogr; 2008 May; 32(2):163-72. PubMed ID: 18379296
    [Abstract] [Full Text] [Related]

  • 20. The role of imaging in the oncological prostate.
    Chabanova E, Lögager VB.
    Acta Radiol; 2008 Feb; 49(1):4. PubMed ID: 18210305
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.